The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a…

Overview of attention for article published in International Journal of Clinical Oncology, February 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

twitter: 9 X users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 3,263 followers.

RT @Hasancagri_y: 🥳New paper 👉 CDK 4-6 inhibitors are also effective in male breast cancer ⁦@aksoysercan⁩ ⁦@ABCGlobalAll⁩ ⁦@OncoAlert⁩ ⁦@On…

Reply Repost Favourite

RT @Hasancagri_y: 🥳New paper 👉 CDK 4-6 inhibitors are also effective in male breast cancer ⁦@aksoysercan⁩ ⁦@ABCGlobalAll⁩ ⁦@OncoAlert⁩ ⁦@On…

Reply Repost Favourite

RT @Hasancagri_y: 🥳New paper 👉 CDK 4-6 inhibitors are also effective in male breast cancer ⁦@aksoysercan⁩ ⁦@ABCGlobalAll⁩ ⁦@OncoAlert⁩ ⁦@On…

Reply Repost Favourite

RT @Hasancagri_y: 🥳New paper 👉 CDK 4-6 inhibitors are also effective in male breast cancer ⁦@aksoysercan⁩ ⁦@ABCGlobalAll⁩ ⁦@OncoAlert⁩ ⁦@On…

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.